Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis outer membrane protein PorA (Porin A) is a major class 1 surface protein that functions as a cation-selective porin, facilitating the diffusion of small hydrophilic solutes across the outer membrane (UniProt: P0A316). It is a primary target for the host immune system and serves as the foundational component of outer membrane vesicle (OMV) vaccines, which are particularly vital for preventing Serogroup B meningococcal disease where the polysaccharide capsule is poorly immunogenic (PubMed: 19471315). Because PorA is highly antigenically variable, modern vaccine strategies often combine OMV-derived PorA with other conserved surface proteins, such as Factor H binding protein (fHbp), Neisserial adhesin A (NadA), and Neisserial Heparin Binding Antigen (NHBA), to ensure broader strain coverage (PubMed: 22939021). These associated proteins play critical roles in bacterial survival by mediating adhesion to host cells and inhibiting the alternative complement pathway (PubMed: 21239671). Therapeutic intervention via OMV-based vaccines aims to elicit high titers of serum bactericidal antibodies that trigger complement-mediated killing and opsonophagocytosis of the pathogen (EMA: Bexsero Assessment Report).
Induction of serum bactericidal antibodies that facilitate complement-mediated lysis and opsonophagocytosis of Neisseria meningitidis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis outer membrane protein PorA and associated surface proteins (PorA).